Detailed Report on Diabetic Nephropathy Market Growth, Size, and Segmentation 2023-2030 Industry Rese - Benzinga
AMPEDelisted Stock | USD 0.24 0.01 4.35% |
About 55% of Ampio Pharm's shareholders are presently thinking to get in. The analysis of overall sentiment of trading Ampio Pharm pink sheet suggests that some investors are interested at this time. The current market sentiment, together with Ampio Pharm's historical and current headlines, can help investors time the market. In addition, many technical investors use Ampio Pharm stock news signals to limit their universe of possible portfolio assets.
Ampio Pharm pink sheet news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Ampio daily returns and investor perception about the current price of Ampio Pharm as well as its diversification or hedging effects on your existing portfolios.
Ampio |
Detailed Report on Diabetic Nephropathy Market Growth, Size, and Segmentation 2023-2030 Industry Rese Benzinga
Read at news.google.com
Ampio Pharm Fundamental Analysis
We analyze Ampio Pharm's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ampio Pharm using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ampio Pharm based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Cash Per Share
Cash Per Share Comparative Analysis
Ampio Pharm is currently under evaluation in cash per share category among its peers. Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.
Ampio Pharm Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Ampio Pharm pink sheet to make a market-neutral strategy. Peer analysis of Ampio Pharm could also be used in its relative valuation, which is a method of valuing Ampio Pharm by comparing valuation metrics with similar companies.
Peers
Ampio Pharm Related Equities
CADL | Candel Therapeutics | 4.55 | ||||
SYBX | Synlogic | 4.17 | ||||
ANTX | AN2 Therapeutics | 3.70 | ||||
ZVSA | ZyVersa Therapeutics | 4.07 | ||||
PULM | Pulmatrix | 4.31 | ||||
ACIU | AC Immune | 4.44 | ||||
REVB | Revelation Biosciences | 4.92 | ||||
RNAZ | Transcode Therapeutics | 4.99 | ||||
QNRX | Quoin Pharmaceuticals | 6.06 | ||||
PHIO | Phio Pharmaceuticals | 6.63 | ||||
GLUE | Monte Rosa | 8.27 | ||||
AKTX | Akari Therapeutics | 9.22 | ||||
ZURA | Zura Bio | 9.96 | ||||
SONN | Sonnet Biotherapeutics | 12.92 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Consideration for investing in Ampio Pink Sheet
If you are still planning to invest in Ampio Pharm check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Ampio Pharm's history and understand the potential risks before investing.
Stocks Directory Find actively traded stocks across global markets | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |